Colleagues examined the efficacy and safety of the BIHAP in patients after total pancreatectomy in a randomized crossover clinical trial. Twelve adult outpatients after total pancreatectomy were randomly assigned to fully closed-loop BIHAP for seven days followed by seven days of current diabetes care (insulin pump or pen therapy) or the same treatments in the reverse order; three patients did not complete the BIHAP phase and one was replaced.
According to research presented by Dr. Andrea Dehn-Hindenberg from the Hannover Medical School in Germany, mothers in children with diabetes experience many challenges in their occupational settings.
Researchers conducted a trial involving youth aged 10.0 to 16.9 years within 21 days of type 1 diabetes diagnosis. Ninety-seven participants were randomly assigned to receive 24 months of hybrid closed-loop therapy or standard insulin therapy. The area under the curve for the plasma C-peptide level at 12 months after diagnosis was assessed as the primary end point.
